Veracyte Statistics
Want to see VCYT full AI Analyst Report?
Veracyte (VCYT) Stock Statistics & Valuation Metrics
Total Valuation
Veracyte has a market cap or net worth of $1.94B. The enterprise value is $3.48B.
- Market Cap
- $1.94B
- Enterprise Value
- $3.48B
Share Statistics
Veracyte has 80,695,480 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 80,695,480
- Owned by Insiders
- 1.69%
- Owned by Institutions
- 93.11%
Financial Efficiency
Veracyte’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 5.34%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 5.34%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 684.96K
- Profits Per Employee
- 87.88K
- Employee Count
- 755
- Asset Turnover
- 0.37
- Inventory Turnover
- 7.65
Valuation Ratios
The current PE Ratio of Veracyte is 15.17. Veracyte’s PEG ratio is 0.05.
- PE Ratio
- 15.17
- PS Ratio
- 3.35
- PB Ratio
- 1.35
- Price to FCF
- 12.06
- Price to Operating Cash Flow
- 11.17
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Veracyte had revenue of 517.14M and earned 66.35M in profits. Earnings per share was 0.84.
- Revenue
- 517.14M
- Gross Profit
- 360.05M
- Operating Income
- 74.15M
- Pretax Income
- 68.20M
- Net Income
- 66.35M
- EBITDA
- 89.62M
- Earnings Per Share (EPS)
- 0.84
Cash Flow
In the last 12 months, operating cash flow was 173.88M and capital expenditures -12.47M, giving a free cash flow of 161.41M billion.
- Operating Cash Flow
- 173.88M
- Free Cash Flow
- 161.41M
- Free Cash Flow per Share
- 2.01
Dividends & Yields
Veracyte pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.33%
- Earnings Yield
- 6.56%
Stock Price Statistics
- Beta
- 1.26
- 52-Week Price Change
- -38.98%
- 50-Day Moving Average
- 42.16
- 200-Day Moving Average
- 42.47
- Relative Strength Index (RSI)
- 27.79
- Average Volume (3m)
- 1.80M
Important Dates
Veracyte upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Veracyte as a current ratio of 8.15, with Debt / Equity ratio of 3.03%
- Current Ratio
- 8.15
- Quick Ratio
- 7.81
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -3.60
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Veracyte has paid 1.85M in taxes.
- Income Tax
- 1.85M
- Effective Tax Rate
- 0.03
Enterprise Valuation
Veracyte EV to EBITDA ratio is 13.40, with an EV/FCF ratio of 11.02.
- EV to Sales
- 3.06
- EV to EBITDA
- 13.40
- EV to Free Cash Flow
- 11.02
- EV to Operating Cash Flow
- 10.23
Balance Sheet
Veracyte has $370.53M in cash and marketable securities with $40.74M in debt, giving a net cash position of $329.80M billion.
- Cash & Marketable Securities
- $370.53M
- Total Debt
- $40.74M
- Net Cash
- $329.80M
- Net Cash Per Share
- $4.09
- Tangible Book Value Per Share
- $4.88
Margins
Gross margin is 72.35%, with operating margin of 15.36%, and net profit margin of 21.80%.
- Gross Margin
- 72.35%
- Operating Margin
- 15.36%
- Pretax Margin
- 19.11%
- Net Profit Margin
- 21.80%
- EBITDA Margin
- 22.81%
- EBIT Margin
- 19.11%
Analyst Forecast
The average price target for Veracyte is $45.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $45.00
- Price Target Upside
- 87.42% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 10
- Revenue Growth Forecast
- 17.50%
- EPS Growth Forecast
- 311.25%
Scores
- Smart Score
- 8
- AI Score
- 70

